A Comparison of the Blood Pressure Changes of Lumiracoxib With Those of Ibuprofen and Naproxen

The 52‐week Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET) investigated the gastrointestinal and cardiovascular safety profile of lumiracoxib 400 mg once daily compared with 2 traditional nonsteroidal anti‐inflammatory drugs (NSAIDs): ibuprofen 800 mg 3 times daily and napr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Hypertens (Greenwich)
Päätekijät: Farkouh, Michael E., Verheugt, Freek W. A., Ruland, Sean, Kirshner, Howard, Jeger, Raban, Gitton, Xavier, Krammer, Gerhard, Stricker, Kirstin, Sallstig, Peter, Mellein, Bernhard, Matchaba, Patrice, Chesebro, James H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Blackwell Publishing Inc 2008
Aiheet:
Original Papers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8109916/
https://ncbi.nlm.nih.gov/pubmed/18772641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2008.07802.x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia